DELIVERY ORDER
Active75F40126F19080
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$140.8K
obligated · signed 4 months ago
VSG TO- NAMS DEVELOPMENT AND DEVELOPMENTAL NEUROTOXICITY
Performance timeline
Start
Jun 10, 2026
End
Jun 9, 2028
with all options
Loading status
Estimated start: Jun 9, 2027
VETS SYNERGETIC GROUP LLC
Contract 75F40126F19080
UEI
CKT7ALMJZL25
Parent Company
VETS SYNERGETIC GROUP LLC
Capabilities & Certifications
Headquarters Location
Congressional District: 10
Current Obligation
$140,837
Base + Exercised Options
$140,837
Total Ceiling Value
$282,110
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES
PSC
SUPPORT- MANAGEMENT: OTHER
Place of Performance
Congressional District: 10
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Contract Vehicle
75F40124D00020
IDCDepartment of Health and Human Services
Award type: SINGLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.